The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed
Abstract
Abstract Reversible posterior leukoencephalopathy is a syndrome of headache, seizures and visual loss, often associated with an abrupt increase in blood pressure. Prompt diagnosis and therapy with antihypertensives, anticonvulsants, removal of any offending medication and treatment of associated disorders is essential since early treatment might prevent progression to irreversible brain damage. We present six illustrative cases presenting to Christchurch Hospital and review the condition. All were hypertensive, two were receiving immunosuppressant therapy after transplantation and one chemotherapy. Only three made a full recovery. The term reversible posterior leukoencephalopathy is a misnomer as the condition is not always reversible, is not necessarily confined to the posterior regions of the brain and can affect both white and grey matter. Magnetic resonance imaging findings of increased T2 and fluid attenuated inversion recovery signal predominantly involving the posterior regions of the cerebral hemispheres should alert the clinician to the possibility of this diagnosis. (Intern Med J 2005; 35: 83–90)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Reversible Posterior Leukoencephalopathy Syndrome
Hinchey, J., Chaves, C., Appignani, B., Breen, J., Pao, L., Wang, A., Pessin, M. S., Lamy, C., Mas, J.-L., & Caplan, L. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340803 · Cited by 3,340
Thrombotic Thrombocytopenic Purpura
(2006) · New England Journal of Medicine · doi:10.1056/nejmc061483 · Cited by 573
Casey, S. O., Sampaio, R. C., Michel, E., & Truwit, C. L. (2000) · PubMed Central · Cited by 559
Vaughan, C. J., & Delanty, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02539-3 · Cited by 508
Posterior leukoencephalopathy without severe hypertension: Utility of diffusion-weighted MRI
Ay, H., Buonanno, F. S., Schaefer, P. W., Le, D. A., Wang, B., Gonzalez, R. G., & Koroshetz, W. J. (1998) · Neurology · doi:10.1212/wnl.51.5.1369 · Cited by 469
Cyclosporine neurotoxicity: a review
Gijtenbeek, J. M. M., van den Bent, M. J., & Vecht, C. J. (1999) · Journal of Neurology · doi:10.1007/s004150050360 · Cited by 429
Treatment of hypertension in pregnant women
Sibai, B. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350407 · Cited by 366
Reversible Posterior Leukoencephalopathy Syndrome: Evaluation with Diffusion-Tensor MR Imaging
Mukherjee, P., & McKinstry, R. C. (2001) · Radiology · doi:10.1148/radiology.219.3.r01jn48756 · Cited by 243
Posterior leukoencephalopathy syndrome may not be reversible
Antunes, N. L., Small, T. N., George, D., Boulad, F., & Lis, E. (1999) · Pediatric Neurology · doi:10.1016/s0887-8994(98)00148-9 · Cited by 201
Cited by
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,054
Sperling, R. A., Jack, C. R., Black, S. E., Frosch, M. P., Greenberg, S. M., Hyman, B. T., Scheltens, P., Carrillo, M. C., Thies, W., Bednar, M. M., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2351 · Cited by 857
Canney, M., Kelly, D., & Clarkson, M. (2015) · American Journal of Nephrology · doi:10.1159/000381316 · Cited by 624
Adverse effects of anticancer agents that target the VEGF pathway
Chen, H. X., & Cleck, J. N. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.94 · Cited by 560
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
(2006) · New England Journal of Medicine · doi:10.1056/nejmc052954 · Cited by 365
Metadata
- Authors
- Stott, V. L., Hurrell, M. A., & Anderson, T. J.
- Venue
- Internal Medicine Journal
- Publisher
- Wiley
- Published
- 2005-02
- Volume
- 35
- Issue
- 2
- Pages
- 83-90
- ISSN
- 1444-0903 (ISSN-L)
- 1445-5994
- OpenAlex
- W2171555539
- Cited by
- 297
- References
- 9
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. https://app.cochat.ai/papers/10.1111/j.1445-5994.2004.00750.x
- The paper
- Stott, V. L., Hurrell, M. A., & Anderson, T. J. (2005). Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Internal Medicine Journal. https://doi.org/10.1111/j.1445-5994.2004.00750.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.